USPTO 2015–2025 USPTO PatentsView US Corporation

Hyalex Orthopaedics, Inc.

USPTO PatentsView assignee record - 14 granted patents across 13 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

The verdict

According to USPTO PatentsView, Hyalex ranks #19,877 of 50,000 tracked US assignees by granted-patent volume, with 14 patents across 13 technology areas.

#19,877
of 50,000 US assignees by volume
Top 37%
by Innovation Score (40.1/100)
23.0
avg claims per patent
+267%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19877 · US Corporation #19,877 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #19,877/50,000
  • PHOTO-FINISH Hong Kong R&D Centre…
  • CPC-FOCUS A61F · 13 areas
  • INNOV-PAR 40.1/100
  • CLAIMS-DENSE 23.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +267% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hong Kong R&D Centre For Logistics And Supply Chain Management Enabling Technologies Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Hyalex

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Hyalex's Innovation Score is 40.1/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Hyalex's grants concentrate

Hyalex Orthopaedics, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2017. By volume, Hyalex sits between Hong Kong R&D Centre For Logistics And Supply Chain Management Enabling Technologies Limited and Hyundai Electric & Energy Systems Co., Ltd..

Who files at Hyalex's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Hyalex holds 14 patents at rank #19,876, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Hyalex

By rank, the assignees closest to #19,876 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Hyalex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hyalex, neither rank-band nor same-CPC leaders (those blocks stay above).

Hyalex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2017201920202021202220232024 1
USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Hyalex Orthopaedics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 7.1%
2019 2 14.3%
2020 3 21.4%
2021 3 21.4%
2022 1 7.1%
2023 3 21.4%
2024 1 7.1%

Which technologies does Hyalex Orthopaedics, Inc. patent most?

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#19,877

of 50,000 tracked assignees

Innovation Score

40.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.